Complaining about a smallcap biotech for the posibility of needing to raise capital at some point in the future and 'speculative being a good description' is sort of stating the obvious isn't it? Speculative is indeed what a small company without revenue is.. It sounds like some of these posters may be better off putting their money into an ETF or a nice set of multi billion $ blue chips.
Complaining about a smallcap biotech for the posibility of...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
